Literature DB >> 15863942

Molecular mechanism of action of selective estrogen receptor modulator in target tissues.

Masahide Ohmichi1, Keiichi Tasaka, Hirohisa Kurachi, Yuji Murata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863942     DOI: 10.1507/endocrj.52.161

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


× No keyword cloud information.
  5 in total

1.  Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134).

Authors:  M Ning; C Zhou; J Weng; S Zhang; D Chen; C Yang; H Wang; J Ren; L Zhou; C Jin; M-W Wang
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

2.  Effects of estrogen on hyperglycemia and liver dysfunction in diabetic male rats.

Authors:  Marwa A Ahmed; Khaled M A Hassanein
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

3.  Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis.

Authors:  Takafumi Majima; Akira Shimatsu; Noriko Satoh; Yasato Komatsu; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

4.  Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats.

Authors:  T Hertrampf; J Seibel; U Laudenbach; K H Fritzemeier; P Diel
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

5.  Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan.

Authors:  Yi-Hsin Chen; Teng-Fu Hsieh; Ching-Chih Lee; Ming-Ju Wu; Yun-Ching Fu
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.